Posts filed under ‘Next-Generation Vaccines and Therapeutics’
The Emory Vaccine Center, under the leadership of GRA Eminent Scholar Rafi Ahmed, is partnering with 42 universities and research institutions in 13 countries to accelerate human vaccine development through a new collaborative research program called Advanced Immunization Technologies (ADITEC).
The partnership, led by Novartis, was launched October 1 with 30 million euros in funding over five years from the European Union and 11 million euros in co-funding from collaborating organizations. ADITEC will develop new technologies and a robust platform for innovation in the next generation of human vaccines. Read more here>
More than 300 university and CDC scientists have registered for the GRA/CDC/CDC Foundation Research Collaboration Symposium on “Hot Topics in Next-Generation Vaccines R&D.” Scheduled for April 25, the Symposium marks the fifth year of programs to promote research collaborations among Georgia university and CDC researchers and to showcase Georgia’s strengths in next-generation vaccine research and development.
The Symposium will feature plenary and breakout sessions focused on “Innate Immunity,” “Inflammation and Infection,” and “Systems Vaccinology.” John Boslego, MD, Global Program Leader, Vaccine Development for PATH, a leading international organization that promotes global heatlth, will present the keynote address.
Registration for the Symposium is now closed.
The Georgia Research Alliance invests in cutting-edge research tools at its partner universities to drive innovative research and development. These laboratory discoveries, in turn, often become the platforms on which new companies are created.
Today, two of those investments — advanced cryo-electron microscopes — were unveiled at Emory University.
One of the microscopes, equipped with phase plate technology, is one of only two such instruments in the United States and just a few in the world. Both instruments use cryo-imaging, which offers layer-by-layer views of a frozen specimen, providing ultra-high-resolution.
The instruments will be located at the Robert P. Apkarian Integrated Electron Microscopy Core (located in Emerson Hall), under the supervision of core director Elizabeth R. Wright, PhD, assistant professor of pediatrics at Emory University School of Medicine and a Georgia Research Alliance Distinguished Investigator.
“We are excited about establishing Emory as a center for cryo-electron microscopy and looking forward to making these resources available to investigators at Emory and within the region,” Wright says.
Parasites that attack the especially vulnerable are subject of new GRA Distinguished Investigator’s research
Boris Striepen’s research can lead to the development of new drugs to treat parasitic diseases
The Universtiy of Georgia today announced that Boris Striepen, who studies AIDS-associated parasites, has been named a Georgia Research Alliance Distinguished Investigator. His appointment is part of a GRA initiative to recruit, retain and support top scientists who conduct research in next-generation vaccines and therapeutics.
According to the UGA news release, the parasites that are the focus of Striepen’s research can cause severe disease in infants, small children and individuals with weakened immune symptoms, such as those suffering from AIDS. The Striepen laboratory uses modern genetic approaches to investigate the unique biology of these parasites in an effort to identify specific targets for intervention.
“Boris has been instrumental in developing UGA’s Center for Tropical and Emerging Global Diseases into one of the world’s premier centers for the study of parasitic diseases of humans, “ said Rick Tarleton, Distinguished Research Professor in the department of cellular biology. “His insights into the metabolism and basic cell biology of apicomplexan parasites that kill millions of people each year are translational and will lead to the development of new drugs. The GRA could not have chosen a more deserving candidate for this honor.”
Our first event of 2010 to foster new collaborations, the Georgia Research Alliance/Centers for Disease Control and Prevention/CDC Foundation Collaboration Roundtable, drew more than 250 scientists from throughout Georgia to the CDC on February 26.
Launched three years ago as part of the GRA Next-Generation Vaccines and Therapeutics Initiative, the Roundtable brings together scientists from eight Georgia universities and from the Centers for Disease Control and Prevention. Together, they explore opportunities to collaborate in early-stage vaccine and therapeutics projects that marshal the immune system to prevent and treat diseases like influenza, cancer, arthritis, HIV/AIDS, Alzheimer’s, diabetes and malaria.
In its first three years, the Roundtable has generated 40+ new collaborations.
Abstracts of the posters presented at the 2010 Roundtable are available at www.gra.org/vaccines.